Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Micafungin - Astellas Pharma

Drug Profile

Micafungin - Astellas Pharma

Alternative Names: FK 463; Funguard; Micafungin sodium; Micamin; Mycamine

Latest Information Update: 06 Sep 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Astellas Pharma
  • Class Antifungals; Echinocandins; Lipoproteins
  • Mechanism of Action Glucan synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Aspergillosis; Candidaemia; Candidiasis

Most Recent Events

  • 04 Jul 2019 Micafungin is not yet available for Candidaemia in Jordan and Syria
  • 04 Jul 2019 Micafungin is not yet available for Candidiasis in Jordan and Syria
  • 30 Jun 2019 Preregistration for Candidiasis (In neonates and infants aged less than 120 days) in USA (IV) (Astellas Pharma pipeline, July 2019)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top